• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Inadequate evidence for cognitive training in preventing cognitive decline

byEvelyn NguyenandDeepti Shroff
December 22, 2017
in Chronic Disease, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In healthy elderly adults, cognitive training enhanced cognitive performance in the area that was trained, but there did not seem to be any effect on adults with mild cognitive impairment (MCI).

2. There was inadequate evidence regarding prevention of dementia or decline in cognition through cognitive training.

Evidence Rating Level: 1 (Excellent)   

Study Rundown: Concerns about cognitive loss due to dementia has stimulated the growth of cognitive training programs that claim to undo some of the effects of aging on the brain.  There is limited information on the effects of these training programs on the start of dementia or cognitive decline.  Therefore, the authors of this systematic review sought to assess the present literature for the effectiveness of cognitive training for prevention of Alzheimer disease and related dementias (ADRD) or cognitive decline.  The authors evaluated 11 trials with adult participants who had normal cognitive abilities or MCI.  The researchers found that cognitive training enhanced cognitive performance for healthy older adults, but only in the domain that was trained.  For example, if memory was trained, memory improved but not reasoning or processing speed.  Cognitive training did not seem to have any effect on adults with MCI. There was inadequate evidence regarding prevention of dementia or decline in cognition through cognitive training.  Therefore, health care providers cannot currently recommend cognitive training for decreasing the risk of dementia or cognitive decline.

A strength of the study is that it provides an updated report of the evidence regarding the use of cognitive training for prevention of dementia or decline in cognition.  Limitations of the study include varied interventions and measurements of outcome, outcomes that tended to evaluate performance on tests rather than overall function, and the possibility of publication bias.

Click to read the study, published in Annals of Internal Medicine

RELATED REPORTS

Dementia diagnosis underreporting is common and associated with reduced care engagement

Older married couples demonstrate domain-specific cognitive concordance 

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Relevant Reading: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia

In-Depth [systematic review]: The authors used EMBASE, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, and PsycINFO to search for pertinent literature that was published from January 2009 to July 2017.  The authors also manually searched the reference lists of certain articles.  To find articles published prior to 2009, the authors used the Agency for Healthcare Research and Quality (AHRQ) review on prevention of decline in cognition and Alzheimer disease.  Qualifying studies were in English, had an intervention of cognitive training with adult participants who had either normal cognitive abilities or MCI, had ≥6 months of follow-up, and gave outcomes of cognitive performance or dementia.  Studies that had a high risk of bias or that included only participants with dementia were excluded.  Of the 11 qualifying trials, 6 had adult participants with normal cognitive abilities, and 5 had adult participants who had MCI.  Most cognitive trainings for healthy elderly adults were computer based, and most trainings for adults with MCI were given in group sessions.  Compared to attention or inactive controls, evidence of moderate strength suggests that training in a certain area may enhance performance in that particular area for adults with normal cognition.  Evidence of low strength suggests that training does not enhance performance for adults with MCI.  The trials for adults with MCI were not as precise as those for adults with normal cognition.  No adverse events were reported.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive declinedementia
Previous Post

QI initiatives improve antibiotic initiation in bone marrow transplant patients

Next Post

Inadequate evidence for OTC supplements in preventing cognitive decline

RelatedReports

Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

August 29, 2026
Neurology

Older married couples demonstrate domain-specific cognitive concordance 

August 28, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
Next Post
Myeloperoxidase upregulation in epileptogenesis seen on molecular imaging

Inadequate evidence for OTC supplements in preventing cognitive decline

Glioblastoma phenotypes identified on MRI predict molecular behavior

2 Minute Medicine Rewind December 25, 2017

Meeting families, demographic information affect child abuse work-up

Kidney failure risk equation (KFRE) discriminates risk in children with chronic kidney disease

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.